BCYC · Bicycle Therapeutics PLC
$4.33
-0.03 (-0.57%)
At close · Aug 27
Market Cap
$304.82M
Shares
69.99M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BCYC
24 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | — | 739,251 | $3,430,125 | 0.03% | Long | 2026-03-31 | |
| SmallCap Fund | — | 516,100 | $2,435,992 | 0.12% | Long | 2026-04-30 | |
| Old Westbury Small & Mid Cap Strategies Fund | — | 265,973 | $1,255,393 | 0.01% | Long | 2026-04-30 | |
| Small-Mid Cap Equity Fund | MSLC | 54,440 | $1,110,576 | 0.18% | Long | 2024-11-30 | |
| iShares Biotechnology ETF | AAXJ | 242,577 | $1,028,526 | 0.01% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Portfolio | — | 62,846 | $291,605 | 0.04% | Long | 2026-03-31 | |
| ALPS Medical Breakthroughs ETF | — | 51,450 | $241,301 | 0.15% | Long | 2026-05-31 | |
| Virtus Biotech Clinical Trials Etf | — | 37,047 | $174,862 | 0.47% | Long | 2026-04-30 | |
| VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | — | 30,052 | $141,845 | 0.02% | Long | 2026-04-30 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | — | 30,512 | $141,576 | 0.02% | Long | 2026-03-31 | |
| Health Sciences Trust | — | 25,602 | $118,793 | 0.05% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 25,129 | $117,855 | 0.00% | Long | 2026-05-31 | |
| AdvisorShares Alpha DNA Equity Sentiment ETF | AADR | 5,344 | $107,361 | 0.93% | Long | 2023-09-29 | |
| Range Cancer Therapeutics ETF | ABUF | 6,304 | $69,155 | 0.77% | Long | 2025-02-28 | |
| Invesco NASDAQ Future Gen 200 ETF | — | 13,410 | $62,893 | 0.33% | Long | 2026-05-31 | |
| Horizon Kinetics Medical ETF | BCDF | 12,584 | $53,356 | 0.28% | Long | 2026-06-30 | |
| Steward Values Enhanced International Fund | — | 11,209 | $52,906 | 0.02% | Long | 2026-04-30 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 9,600 | $40,704 | 0.02% | Long | 2026-06-30 | |
| Harbor International Core Fund | — | 6,102 | $28,801 | 0.00% | Long | 2026-04-30 | |
| TIFF MULTI-ASSET FUND | — | 3,375 | $15,660 | 0.00% | Long | 2026-03-31 | |
| Invesco Nasdaq Biotechnology ETF | — | 2,439 | $11,439 | 0.02% | Long | 2026-05-31 | |
| ProShares Ultra Nasdaq Biotechnology | — | 1,711 | $8,025 | 0.01% | Long | 2026-05-31 | |
| Harbor Disruptive Innovation ETF | ACOM | 276 | $6,471 | 0.18% | Long | 2024-10-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,100 | $5,104 | 0.00% | Long | 2026-03-31 |
Showing 1–24 of 24 positions
Key facts
CIK
1761612
CUSIP
088786108
13F (30d)
93 filings
92 filers
Visit website
Investor relations